BetMakers executes strategic operational restructure and accelerates path to profitability, sending shares 20% higher on the stockmarket today.
Aroa Biosurgery [ASX:ARX] Posts FY23 Results and Shares FY24 Outlook
Biotech Aroa has released its audited results for the 2023 financial year, hitting targets and achieving its expectations. The company looks ahead with a positive perspective on FY24, with the group providing new guidance today.
Droneshield [ASX:DRO] Ramps Up Operations and Production
DroneShield has ramped up operations and production with numerous orders in the pipeline and having received $13.9 million in cash receipts, with a further $2 million coming in tax incentives.
Wesfarmers [ASX:WES] Talks Strategies for Evolving Retail Environment
Retail giant Wesfarmers has released a businesses health report, assessing the current environment and analysing strategies to make the most of current conditions.
ALS [ASX:ALQ] Delivers 23.4% Underlying NPAT Increase for FY23
ALS has reported underlying NPAT of $321 million for FY2023 — an increase of 23.4% on last year thanks to high-performing divisions.
SmartPay [ASX:SMP] Posts Revenue Increase of 62% and Earnings are up by 81% for 2023
Financial solutions business SmartPay Holdings has returned a 62% increase in revenue on the prior year with $77.8 million, with earnings up 81% and higher profit. Shares were riding in response to the bumper year.
Mesoblast [ASX:MSB] Trims Losses US$2.7 Million and Shares Rise
Biotech company Mesoblast has released its Q3 financial report, saying that it cut losses after tax to US$18.6 million from US$21.3 million a year ago. Shares rose more than 4% during the group’s quarter improvement.
Appen [ASX:APX] Alerts of AI and Tech Slowdown in US
Chair of Appen Richard Freudenstein cast a sobering reflection on the group’s most recent performance, and over the broader technology industry, stating at the company’s AGM that 2022 was ‘far from satisfactory’.
Fisher & Paykel Healthcare [ASX:FPH] Shares Fall with Profits
FPH experienced a 34% slump in net profit in FY23, and shares were falling more than 4% in the hours that followed the news.
Universal Store [ASX:UNI] Ups Guidance Yet Shares Plummet 27%
Universal Store has upgraded its guidance on group sales to be in the range of $258 million to $261 million for FY23 with underlying EBIT also higher yet shareholders were downvoting shares by more than 27% on a bleak spending outlook.
